Clinical characteristics and follow-up results in 30 patients (34 lesions) with residual plaque ulceration
Patient No./Age (y)/Sex | Side | Stenosis (%) | Symptoms* before CAS | Size of Residual Ulcer† (mm) | Follow-up Angiography | Symptoms* during Follow-up | Follow-up Period (mo) | ||
---|---|---|---|---|---|---|---|---|---|
Period (mo) | Ulcer | Restenosis | |||||||
1/74/M | L | 48 | + | 2.3 × 6 | 7 | Improved | None | − | 48 |
2/59/M | L | 43 | + | 1.5 × 8 | NA | − | 47 | ||
3/64/M | L | 60 | − | 1.5 × 8 | NA | − | 45 | ||
4/68/M | L | 62 | − | 2 × 6 | 12 | Disappeared | 20% | − | 25‡ |
5/53/M | L | 73 | + | 2.6 × 3 | NA | − | 41 | ||
6/71/M | L | 75 | + | 2.2 × 6 | 4 | Disappeared | None | − | 34 |
R | 62 | + | 2.8 × 11 | 21 | Improved | None | − | 33 | |
7/75/M | R | 62 | + | 1.8 × 8 | NA | − | 31‡ | ||
8/76/M | R | 87 | + | 1.2 × 2 | 6 | Improved | 30% | − | 36 |
9/73/M | L | 81 | + | 1.5 × 6 | 12 | Disappeared | 20% | − | 32 |
10/73/M | R | 78 | − | 2.4 × 6 | 4 | Improved | None | − | 30 |
11/71/M | R | 80 | − | 1 × 6 | NA | − | 30 | ||
12/72/M | R | 86 | + | 1.2 × 6 | 5 | Disappeared | None | − | 28 |
L | 75 | + | 2 × 5 | 3 | No change | 20% | − | 26 | |
13/66/F | R | 40 | + | 2.8 × 13 | 3 | Disappeared | None | − | 28 |
14/50/M | R | 48 | + | 1 × 11 | NA | − | 28 | ||
15/69/M | L | 90 | + | 1.2 × 8 | 2 | Improved | None | − | 26 |
R | 33 | + | 1.8 × 2.5 | NA | − | 24 | |||
16/74/M | R | 52 | − | 1.8 × 8 | 4 | Improved | None | − | 25 |
17/75/M | R | 56 | + | 1.8 × 12 | NA | − | 23 | ||
18/67/M | L | 30 | + | 2.8 × 15 | 10 | Improved | 20% | − | 22 |
19/60/M | L | 88 | + | 2 × 10 | 5 | Improved | 20% | − | 22 |
20/79/M | L | 78 | + | 2 × 8 | NA | − | 3‡ | ||
21/70/M | R | 33 | + | 3.3 × 12 | 1 | Disappeared | None | − | 21 |
L | 36 | + | 2.8 × 9 | 1 | Disappeared | None | − | 20 | |
22/75/F | L | 64 | − | 2.4 × 11 | 4 | Improved | None | − | 20 |
23/65/M | R | 52 | + | 3.8 × 14 | 9 | Disappeared | None | − | 20 |
24/79/M | L | 50 | − | 1.5 × 6 | 4 | Disappeared | None | − | 15 |
25/81/M | R | 45 | + | 4.7 × 11 | 4 | Disappeared | 20% | − | 16 |
26/77/F | R | 32 | + | 1 × 18 | 4 | Improved | None | − | 15 |
27/80/M | L | 62 | + | 2.6 × 10 | 5 | No change | None | − | 15 |
28/81/F | R | 95 | + | 1.8 × 12 | 4 | Improved | 20% | − | 14 |
29/72/F | R | 70 | + | 1.2 × 22 | 6 | Disappeared | None | − | 14 |
30/76/M | L | 71 | + | 1.5 × 1.5 | 4 | Disappeared | 30% | − | 9 |
Note:—CAS indicates carotid artery stenting; NA, not applicable.
* Ipsilateral ischemic neurologic symptoms.
† Depth × length.
‡ These patients died: patient 4 from interstitial pneumonia, patient 7 from myocardial infarction, and patient 20 from brain stem hemorrhage.